176 related articles for article (PubMed ID: 35639475)
21. Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phase 3 trials.
Mullol J; Laidlaw TM; Bachert C; Mannent LP; Canonica GW; Han JK; Maspero JF; Picado C; Daizadeh N; Ortiz B; Li Y; Ruddy M; Laws E; Amin N
Allergy; 2022 Apr; 77(4):1231-1244. PubMed ID: 34459002
[TBL] [Abstract][Full Text] [Related]
22. Cortactin expression in nasal polyps of Aspirin-Exacerbated Respiratory Disease (AERD) patients.
Brescia G; Parrino D; Nicolè L; Zanotti C; Lanza C; Barion U; Marino F; Marioni G
Am J Otolaryngol; 2018; 39(3):293-298. PubMed ID: 29534838
[TBL] [Abstract][Full Text] [Related]
23. [Importance of aspirin challenges in patients with NSAID-exacerbated respiratory disease].
Förster-Ruhrmann U; Olze H
HNO; 2024 Jul; 72(7):494-498. PubMed ID: 38597968
[TBL] [Abstract][Full Text] [Related]
24. The prevalence of Samter's triad in patients undergoing functional endoscopic sinus surgery.
Kim JE; Kountakis SE
Ear Nose Throat J; 2007 Jul; 86(7):396-9. PubMed ID: 17702319
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature.
Rajan JP; Wineinger NE; Stevenson DD; White AA
J Allergy Clin Immunol; 2015 Mar; 135(3):676-81.e1. PubMed ID: 25282015
[TBL] [Abstract][Full Text] [Related]
26. NSAID-exacerbated respiratory disease: a population study.
Andersén H; Ilmarinen P; Honkamäki J; Tuomisto LE; Hisinger-Mölkänen H; Backman H; Lundbäck B; Rönmark E; Haahtela T; Sovijärvi A; Lehtimäki L; Piirilä P; Kankaanranta H
ERJ Open Res; 2022 Jan; 8(1):. PubMed ID: 35083326
[TBL] [Abstract][Full Text] [Related]
27. Heterogeneity of NSAID-Exacerbated Respiratory Disease: has the time come for subphenotyping?
Kowalski ML
Curr Opin Pulm Med; 2019 Jan; 25(1):64-70. PubMed ID: 30489335
[TBL] [Abstract][Full Text] [Related]
28. Aspirin desensitization following endoscopic sinus surgery is effective in patients with nonsteroidal antiinflammatory drug exacerbated respiratory disease.
Aydin Ö; Atmiş EÖ; Anadolu Y; Yorulmaz İ; Çelik GE
J Asthma; 2023 Jun; 60(6):1131-1140. PubMed ID: 36218308
[TBL] [Abstract][Full Text] [Related]
29. Samter's triad in childhood: a warning for those prescribing NSAIDs.
Ameratunga R; Randall N; Dalziel S; Anderson BJ
Paediatr Anaesth; 2013 Aug; 23(8):757-9. PubMed ID: 23782034
[TBL] [Abstract][Full Text] [Related]
30. Aspirin-exacerbated respiratory disease and current treatment modalities.
Sakalar EG; Muluk NB; Kar M; Cingi C
Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1291-1300. PubMed ID: 27538737
[TBL] [Abstract][Full Text] [Related]
31. Monoclonal antibody or aspirin desensitization in NSAID-exacerbated respiratory disease (N-ERD)?
Van Broeck D; Steelant B; Scadding G; Hellings PW
Front Allergy; 2023; 4():1080951. PubMed ID: 37123562
[TBL] [Abstract][Full Text] [Related]
32. Algorithmic Identification of Patients With Aspirin-Exacerbated Respiratory Disease Using an Electronic Health Record.
Tao M; Roberts S; Arnold M
Otolaryngol Head Neck Surg; 2023 Aug; 169(2):253-257. PubMed ID: 36939473
[TBL] [Abstract][Full Text] [Related]
33. Inflammatory macrophage memory in nonsteroidal anti-inflammatory drug-exacerbated respiratory disease.
Haimerl P; Bernhardt U; Schindela S; Henkel FDR; Lechner A; Zissler UM; Pastor X; Thomas D; Cecil A; Ge Y; Haid M; Prehn C; Tokarz J; Heinig M; Adamski J; Schmidt-Weber CB; Chaker AM; Esser-von Bieren J
J Allergy Clin Immunol; 2021 Feb; 147(2):587-599. PubMed ID: 32540397
[TBL] [Abstract][Full Text] [Related]
34. Aspirin or other nonsteroidal inflammatory agent exacerbated asthma.
Ledford DK; Wenzel SE; Lockey RF
J Allergy Clin Immunol Pract; 2014; 2(6):653-7. PubMed ID: 25439353
[TBL] [Abstract][Full Text] [Related]
35. [Asthma exacerbation due to preoperative NSAID use].
Miry T; van der Sar-van der Brugge S; van der Rijt AJM
Ned Tijdschr Geneeskd; 2021 Mar; 165():. PubMed ID: 33720565
[TBL] [Abstract][Full Text] [Related]
36. Nonsteroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease phenotype: Topical NSAID and asthma control - A possible oversight link.
Tan JHY; Hsu AAL
Respir Med; 2016 Sep; 118():1-3. PubMed ID: 27578463
[TBL] [Abstract][Full Text] [Related]
37. Dupilumab increases aspirin tolerance in NSAID-exacerbated respiratory disease.
Schneider S; Poglitsch K; Morgenstern C; Quint T; Gangl K; Sinz C; Bartosik T; Campion NJ; Liu DT; Landegger LD; Tu A; Stanek V; Rocha-Hasler M; Bangert C; Eckl-Dorna J
Eur Respir J; 2023 Mar; 61(3):. PubMed ID: 36549708
[TBL] [Abstract][Full Text] [Related]
38. A novel treatment adjunct for aspirin exacerbated respiratory disease: the low-salicylate diet: a multicenter randomized control crossover trial.
Sommer DD; Rotenberg BW; Sowerby LJ; Lee JM; Janjua A; Witterick IJ; Monteiro E; Gupta MK; Au M; Nayan S
Int Forum Allergy Rhinol; 2016 Apr; 6(4):385-91. PubMed ID: 26751262
[TBL] [Abstract][Full Text] [Related]
39. The prevalence of aspirin hypersensitivity in patients with nasal polyposis and contributing factors.
Bavbek S; Dursun B; Dursun E; Korkmaz H; Sertkaya Karasoy D
Am J Rhinol Allergy; 2011; 25(6):411-5. PubMed ID: 22185746
[TBL] [Abstract][Full Text] [Related]
40. A multicenter approach to evaluate omalizumab effectiveness in Samter's triad.
Cameli P; D'Alessandro M; Bergantini L; Silvestri E; Romaldi A; Emmi G; Parronchi P; Bargagli E
Monaldi Arch Chest Dis; 2020 Aug; 90(3):. PubMed ID: 32885934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
